CD8A and melanoma: These findings demonstrate that proliferating tumour cells and dormant MeSCs respond differently to immune signals, and they strongly support the dual activity of CD8+ T-cells, as observed by others24, 25, 56, which simultaneously maintain MeSC quiescence and eradicate more mature melanoma cells.